BioReliance Names Darryl L. Goss to Lead New Toxicology/LADS Business Unit.ROCKVILLE, Md. -- BioReliance Corporation announced today Darryl L. Goss n. 1. Gorse. has been appointed Vice President, Toxicology/Laboratory Animal Diagnostic Services diagnostic services, n.pl the imaging and laboratory capabilities available for determining the cause of an illness. (LADS), a new executive position created to lead this newly formed Business Unit. Goss, who was previously Vice President, Global Process Excellence at BioReliance, will continue to serve on the company's Operating Committee and report to David A. Dodd, President, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. and Chairman, BioReliance Corporation. BioReliance Corporation is a leading contract services company that provides biologics safety testing, toxicology toxicology, study of poisons, or toxins, from the standpoint of detection, isolation, identification, and determination of their effects on the human body. Toxicology may be considered the branch of pharmacology devoted to the study of the poisonous effects of drugs. , viral manufacturing and laboratory animal diagnostic services to the pharmaceutical and biopharmaceutical industries worldwide. Mr. Goss will have direct responsibility for the operations and commercialization of the company's new Toxicology/LADS Business Unit, which combines the company's separate toxicology and LADS services. Other senior managers assigned to the Toxicology/LADS unit, reporting to Mr. Goss, include: * David Bruning, appointed to Senior Director, Business Operations Business operations are those activities involved in the running of a business for the purpose of producing value for the stakeholders. Compare business processes. The outcome of business operations is the harvesting of value from assets , responsible for sales, marketing, business development and program management activities; * David McClelland David Clarence McClelland (1917 – March 27, 1998) was an American personality psychologist, social psychologist, and an advocate of quantitative history. McClelland earned his BA in 1938 at Wesleyan University, his MA in 1939 at the University of Missouri, and his Ph. , appointed to Director, Genetic Toxicology Operations, responsible for all laboratory operations in support of gene toxicology services; * Eias Zahalka Ph.D., appointed to Director, Mammalian Toxicology Operations, responsible for all laboratory operations in support of mammalian toxicology services; * Daniel Aparicio, appointed Director, LADS Operations, responsible for all laboratory operations in support of LADS. "With his strong leadership skills and industry experience, Darryl is the ideal person to accelerate the growth of this critically important Business Unit," said David A. Dodd, President, CEO and Board Chairman of BioReliance. "Our toxicology and LADS groups already rank among the world's best, and are trusted by the world's largest pharmaceutical and biopharmaceutical companies, discovery firms and government agencies, to deliver excellent testing performance. I am confident this new Business Unit, with its experienced staff and under Darryl's leadership, will serve our existing and new clients at the highest level, accelerating our growth in this key area." "I look forward to the opportunity to work with the outstanding professionals in this business unit, who are among the finest in our industry," said Mr. Goss. "We are committed to providing the very highest levels of testing services with on-time delivery to our valued clients. In addition, we are planning to strategically expand our services to meet the evolving needs of our clients." Mr. Goss has served as Vice President, Global Process Excellence since joining BioReliance in September 2007. Previously, he was Senior Vice President and COO of Esoterix, Inc., following its acquisition by LabCorp. From 2000 to 2005, he held a variety of executive positions at Esoterix including Senior Vice President of Business Operations and Chief Information Officer. From 1993 to 2000, he worked at Covance Central Laboratory Services, Inc., serving in several capacities including Vice President of Information Technology and Services. Prior to Covance, he held various information technology and business development positions with Smith Kline Beecham Clinical Laboratories, Guidance Opportunity, Inc., Beatrice Hunt-Wesson and IBM (International Business Machines Corporation, Armonk, NY, www.ibm.com) The world's largest computer company. IBM's product lines include the S/390 mainframes (zSeries), AS/400 midrange business systems (iSeries), RS/6000 workstations and servers (pSeries), Intel-based servers (xSeries) . Mr. Goss received a Master of Business Administration from University of Chicago, completed post-graduate work in Advanced Management at Oxford University in Oxford, England, and received his Bachelor of Arts degree from the University of California The University of California has a combined student body of more than 191,000 students, over 1,340,000 living alumni, and a combined systemwide and campus endowment of just over $7.3 billion (8th largest in the United States). Davis. In addition to the Toxicology/LADS Business Unit, BioReliance includes the existing Biologics Business Unit. About BioReliance BioReliance Corporation is a leading specialist provider of cost-effective contract services to the pharmaceutical and biopharmaceutical industries, offering more than 1,000 tests or services related to biologics safety testing, in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. and in vivo in vivo /in vi·vo/ (ve´vo) [L.] within the living body. in vi·vo adj. Within a living organism. in vivo adv. toxicology, viral manufacturing, GMP GMP (guanosine monophosphate): see guanine. manufacturing, pre-clinical testing and lab animal health diagnostics. Founded in 1947 as Microbiological Associates, BioReliance is headquartered in Rockville, Maryland Rockville is the county seat of Montgomery County, Maryland, United States. According to the 2006 census update, the city had a total population of 59,114, making it the second largest city in Maryland. , and has primary facilities in Rockville, Glasgow, Scotland , Stirling, Scotland, and Edinburgh, Scotland, employing more than 700 people globally. For more information, visit www.bioreliance.com. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion